Juana Lucia Flores-Candia

Juana Lucia Flores-Candia is an accomplished professional currently serving as a Member of the Management Board at SNOMED International and Chief Innovation Officer at AtG Therapeutics. With expertise in advanced cancer therapies and precision medicine, Juana also holds advisory board positions at NORGANOID GmbH and Probando, and is a Partner at phraktion, a BioPharma consultancy. Juana's previous roles include Board Member at leadXpro AG and The Alliance for Artificial Intelligence in Healthcare, and VP of Strategy & Business Development at Scailyte, where significant commercial pipelines were developed. Juana's extensive experience is complemented by a Ph.D. in Biotechnology and multiple Executive MBA degrees focusing on corporate strategy in healthcare.